George Ng has held various leadership positions in the pharmaceutical and biotech industry, currently serving as CEO and Board Director at Processa Pharmaceuticals. With a background in law and biochemistry, George has been involved in multiple companies as a board member, partner, and managing director. Notably, George played a key role in forming a joint venture between Yuhan Corporation and Sorrento Therapeutics.
This person is not in any teams
TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.